CatalystPit

ALGSAligos Therapeutics, Inc.

NASDAQ · Biological Products, (No Diagnostic Substances)
Last close $5.63 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBiological Products, (No Diagnostic Substances)
Market cap$239.89M
INSTITUTIONAL OWNERSHIP
Institutional holders36
Shares held2,748,315
Value$15.43M
Percent of shares outstanding6.45%
As of quarter end2026-06-30
RECENT NEWS
  • Aligos announces five abstracts accepted for Liver Meeting 2026
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS